PBH Earning Date, Earning Analysis and Earning Prediction
Earning Analysis
Welcome to our in-depth analysis of Prestige Consumer Healthcare Inc(PBH) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Prestige Consumer Healthcare Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
Name
EPS
Revenue
Price Reaction
Fiscal Quarter
Earning Date
Time
Estimate
Actual
Surprise%
Estimate
Actual
Surprise%
1D
5D
FY2026Q2
2025-11-06
Pre-Market
0.97
1.07
+10.31
257.24M
274.11M
+6.56
+2.56
+1.25
FY2026Q1
2025-08-07
Pre-Market
1.00
0.95
-5.00
260.36M
249.53M
-4.16
-10.05
-13.11
FY2025Q4
2025-05-08
Pre-Market
1.30
1.32
+1.54
289.53M
296.52M
+2.41
+6.92
+6.83
FY2025Q3
2025-02-06
Pre-Market
1.16
1.22
+5.17
287.13M
290.32M
+1.11
+14.78
+10.66
FY2025Q1
2024-08-08
Pre-Market
0.87
0.90
+3.45
260.42M
267.14M
+2.58
-1.55
-0.60
FY2024Q4
2024-05-14
-
1.14
1.02
-10.53
287.36M
276.99M
-3.61
+1.38
-8.23
FY2024Q3
2024-02-08
-
1.04
1.06
+1.92
280.36M
282.74M
+0.85
+9.36
+7.61
FY2024Q1
2023-08-03
-
1.01
1.06
+4.95
278.35M
279.31M
+0.34
+0.94
-1.32
-
2023-05-04
-
1.04
1.07
+2.88
-
-
-
+1.26
-4.13
-
2023-02-02
-
1.01
1.04
+2.97
-
-
-
-8.82
-8.17
PBH Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Prestige Consumer Healthcare Inc reported performance for FY2026Q2, announced on 2025-11-06. The company achieved an EPS of 1.07, compared to analyst estimates of 0.97 by 10.31% . Revenue for the quarter reached 274.11M compared to expectations of 257.24M by 6.56% .
The stock price reacted with a 2.56% one-day change and a 1.25% five-day change following the earnings release. These movements reflect market reaction in Prestige Consumer Healthcare Inc growth trajectory and strategic initiatives.
PBH Earnings Forecast
Looking ahead, Prestige Consumer Healthcare Inc(PBH) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2026/Q3 project quarter revenue of 286.93M and an EPS of 1.18.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2026 have been Revise Upward by 0.11%, while EPS estimates have been Revise Upward by 0.48%. For the upcoming Q3 2026, revenue estimates have been adjusted Revise Downward by -3.15% . These revisions correlate with a -2.12% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Prestige Consumer Healthcare Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between PBH's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2026
Revise Upward
+0.11%
In Past 3 Month
EPS Estimates for FY2026
Revise Upward
+0.48%
In Past 3 Month
Revenue Estimates for Q3 2026
Revise Downward
-3.15%
In Past 3 Month
Stock Price
Go Down
-2.12%
In Past 3 Month
1Y
3Y
5Y
Currency: USD
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2026:1.11B
--
EPS Estimate-Annual FY 2026:4.55
—
Stock Price61.86
PBH Revenue and EPS Performance: A Historical Perspective
Prestige Consumer Healthcare Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2026Q2 (2025-11-06,Pre-Market):
EPS: 1.07 (Actual) vs.0.97 (Estimate) (10.31%)
Revenue: 274.11M (Actual) vs. 257.24M (Estimate) (6.56%)
Price Reaction:2.56%(1-Day), 1.25%(5-Day)
FY2026Q1 (2025-08-07,Pre-Market):
EPS: 0.95 (Actual) vs.1.00 (Estimate) (-5.00%)
Revenue: 249.53M (Actual) vs. 260.36M (Estimate) (-4.16%)
Price Reaction:-10.05%(1-Day), -13.11%(5-Day)
FY2025Q4 (2025-05-08,Pre-Market):
EPS: 1.32 (Actual) vs.1.30 (Estimate) (1.54%)
Revenue: 296.52M (Actual) vs. 289.53M (Estimate) (2.41%)
Price Reaction:6.92%(1-Day), 6.83%(5-Day)
Earnings Reaction
The chart below shows how PBH performed 10 days before and after its earnings report, based on data from the past quarters. Typically, PBH sees a -0.64% change in stock price 10 days leading up to the earnings, and a -3.02% change 10 days following the report. On the earnings day itself, the stock moves by +1.68%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed -2.30% on the day following the earnings release and then changed by -3.57% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
People Also Watch
Frequently Asked Questions
What were the key highlights of PBH's latest earnings report for FY2026Q2?
PBH reported its FY2026Q2 earnings on 2025-11-06, showcasing a revenue of 274.11M against an estimate of 257.24M, resulting in a 6.56% surprise. The EPS was 1.07, surpassing the expected 0.97 by 10.31% . The stock experienced a 2.56% price change on the earnings day and a 1.25% change over the next five days, reflecting market reactions to the results.
How did PBH's stock price react after the FY2026Q2 earnings release?
Following PBH's FY2026Q2 earnings announcement on 2025-11-06, the stock price moved by 2.56% on the day of the release. Over the subsequent five days, it saw a 1.25% change. Historically, PBH's stock price tends to shift by an average of -0.64% in the 10 days leading up to earnings and -3.02% in the 10 days following, providing insight into potential market.
What are the revenue and EPS estimates for PBH for 2026/Q3?
For 2026/Q3, analysts estimate PBH’s annual revenue to reach 286.93M, while the EPS is projected at 1.18. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 0.11% and EPS estimates Revise Downward by -3.15% over the past three months, indicating analyst expectation in the company’s performance.
How does PBH's stock price correlate with earnings forecast revisions?
The correlation between PBH's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were Revise Upward by 0.11%, while EPS estimates moved Revise Downward by -3.15% . This trend suggests that price dips could present buying opportunities for investors.
What should investors expect from PBH's next earnings report?
Based on historical trends, PBH's stock price typically moves by -0.64% in the 10 days before its earnings and -3.02% in the 10 days after. For the upcoming 2026/Q3 earnings, analysts expect an EPS of 1.18 and revenue of 286.93M.
What is the sentiment in Prestige Consumer Healthcare Inc (PBH) Q2 2026 Earnings Call Summary?
The earnings call summary reflects a mix of positive and negative elements. Basic financial performance is challenged by supply chain issues and declining revenue guidance, while product development and market strategy show potential for recovery and growth. Expenses are manageable with expected cash flow, but the lack of clear guidance and uncertainties in specific areas like Clear Eyes recovery and e-commerce order patterns contribute to a neutral sentiment. Given the market cap, the stock is likely to experience minor fluctuations, resulting in a neutral prediction for the next two weeks.
